Tristar Wellness Solutions, Inc. (TWSI)

[Penny Nickel Dine]

TWSI Making Move Towards Profitability
By: staff reporter, John Bodger
Last Updated: August 17, 2015 1:45 PM EST

(NEW YORK)--TriStar Welness Solutions, Inc. (OTC:TWSI), a health and wellness company, may be moving towards profitability as their gross margins are indicated to show continued improvement.

In a 10Q-NT filing late Friday TWSI indicated they would show increased gross margins based on their out sourcing manufacturing of their HemCon products to a third party. This has had the effect in decreasing TWSI's net loss dramatically, and may be setting the stage for the company to post a profit this year,

TWSI cost of goods sold for the three months ended March 31, 2015 was $398,000, compared to $1,038,000 for the same period in 2014. The Company's gross margins increased significantly for the three months ended March 31, 2015 compared to March 31, 2014, primarily due to their transition from in-house manufacturing of their HemCon products to utilizing outsourced, third-party manufacturers. This transition began in December 2014.

Based on these improved gross margins TWSI operating loss decrease nearly 50% to approximately ($583,000) for the three months ended March 31, 2015, compared to an operating loss of ($1,207,000) for the three months ended March 31, 2014.

Based on these increased gross margins, and rapidly decreasing net loss, TWSI may be on path to potentially become profitable sometime in fiscal 2015.

To get an idea of the possible interest in this sector one can look at Arch Theraputices, Inc. (OTC:ARTH), which recently say its stock rally from $0.20 to near $0.40 on very high volume. ARTH is another hemostatic company that is pre-clinical trials, where as TWSI current holds both FDA and CFDA approval in the US and China.

TWSI currently has around 25 million shares issued and outstanding, and was last traded around $0.13 per share. http://www.otcmarkets.com/stock/twsi/quote

About TriStar Wellness Solutions, Inc.

TriStar Wellness Solutions (OTC:TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beauty de MamanTM brand of women's health products. Additional information is available at www.tstarwellness.com

http://wallstreetnewscast.com/news/2015/08/twsi-5209.html